Last reviewed: June 21, 2026
Last updated: June 21, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Both Mounjaro (tirzepatide) and Wegovy (semaglutide) have shown clinical effectiveness for weight management, but they activate different metabolic pathways in your body. Mounjaro targets two hormone receptors while Wegovy targets one, which can influence both results and individual response rates. Understanding these differences helps you make an informed decision about which medication may be right for you.
How Mounjaro and Wegovy Work Differently in Your Body
Wegovy contains semaglutide, a GLP-1 receptor agonist that signals your brain to feel fuller, eat less, and slow stomach emptying. This single-pathway approach has demonstrated consistent weight loss results across large patient populations. Semaglutide works primarily by reducing hunger signals and improving appetite control.
Mounjaro contains tirzepatide, a dual GIP/GLP-1 receptor agonist that activates two separate hormonal pathways instead of one. The additional GIP receptor activation may enhance glucose metabolism and metabolic rate beyond what semaglutide alone provides. This dual-action mechanism is why some patients experience more pronounced weight loss with tirzepatide compared to semaglutide monotherapy.
Clinical Weight Loss Results: Tirzepatide vs Semaglutide
Clinical trials show tirzepatide produced average weight loss of 22% of body weight at the highest maintenance dose, compared to semaglutide's average of 15% in similar study populations. These differences reflect the additional metabolic effects of the GIP receptor pathway activation. However, individual results vary significantly based on genetics, lifestyle, and how your body responds to dual versus single receptor stimulation.
Semaglutide remains highly effective for many patients, particularly those who tolerate it well and achieve their weight loss goals with consistent use. The choice between these medications should reflect not just trial averages but your personal metabolic profile and health objectives. Some patients achieve excellent results with semaglutide and experience fewer side effects, making it the optimal choice despite tirzepatide's higher average outcomes in research.
Cost and Accessibility: Comparing Your Options
PlexusDx offers compounded Semaglutide Injection starting at $149 per month and compounded Tirzepatide Injection starting at $249 per month through licensed 503A pharmacies. Both medications are available without insurance requirements or membership fees, with HSA and FSA eligibility. Your dose may need to go up. Your price won't—pricing remains flat regardless of titration level.
For patients seeking both medications combined, PlexusDx offers GLP-Squared Injection (semaglutide plus tirzepatide combination therapy) starting at $249 per month. Oral formulations of both compounds are also available if injection therapy isn't your preference. PlexusDx serves all 50 states, making these options accessible regardless of geographic location or local pharmacy availability.
Which Medication Might Work Better for You: Genetic Insights
Your genetic profile influences how effectively your body responds to GLP-1 and GIP receptor activation. Variants in genes like GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) affect how your appetite regulation and metabolic pathways function. PlexusDx Precision Peptide Genetic Test analyzes these and 46 additional peptide-pathway variants to identify your predisposition to response from different medication approaches.
Patients with certain genetic profiles may experience superior results and fewer side effects with tirzepatide's dual-pathway activation, while others show equal effectiveness with semaglutide's single-pathway mechanism. Understanding your peptide genetics helps PlexusDx clinicians recommend the medication most likely to align with your body's natural metabolic strengths. The Precision Peptide Genetic Test is available as a $99 add-on after your first month of treatment, providing personalized guidance for optimizing long-term outcomes.
Side Effects and Tolerability Considerations
Both semaglutide and tirzepatide commonly cause gastrointestinal side effects including nausea, vomiting, and changes in bowel habits, particularly during dose escalation. These effects typically diminish as your body adjusts over several weeks. Tirzepatide may cause slightly more GI side effects due to dual pathway activation, though this varies individually and some patients tolerate tirzepatide better than semaglutide.
Pancreatitis risk, thyroid concerns, and gallbladder effects have been monitored in clinical use of both medications, though serious events remain rare. Your medical history, medications, and individual tolerance profile should guide the choice between these options. PlexusDx clinicians review your full health picture when recommending semaglutide versus tirzepatide, ensuring safety alongside efficacy.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is Mounjaro or Wegovy more effective for rapid weight loss?
Clinical trials show tirzepatide (Mounjaro) produces approximately 22% average weight loss versus semaglutide (Wegovy) at 15% average, but individual results vary substantially. Your genetic makeup, lifestyle adherence, and metabolic factors influence real-world outcomes more than medication alone. PlexusDx Precision Peptide Genetic Testing can help identify which medication aligns with your specific metabolic strengths.
Can I switch from Wegovy to Mounjaro if I'm not seeing results?
Yes, switching between semaglutide and tirzepatide is clinically appropriate if initial therapy produces inadequate results or causes intolerable side effects. The transition typically involves pausing one medication and starting the other at a low dose, avoiding overlapping receptor activation. PlexusDx clinicians can guide safe transitions and assess whether your genetics predict better response to tirzepatide's dual-pathway approach.
How does PlexusDx pricing compare for these two medications?
PlexusDx compounded Semaglutide Injection starts at $149 per month while compounded Tirzepatide Injection starts at $249 per month, with flat pricing across all dose levels. Both are available without insurance, with HSA/FSA eligibility, across all 50 states. For combined therapy, GLP-Squared Injection starts at $249 per month.
Which medication has fewer side effects, semaglutide or tirzepatide?
Side effect profiles are similar, with GI effects being most common for both, though tirzepatide may cause slightly more nausea during titration due to dual pathway activation. Tolerability is highly individual—some patients experience minimal side effects with tirzepatide while others tolerate semaglutide better. Starting at low doses and titrating gradually with either medication minimizes adjustment-phase symptoms.
How does the Precision Peptide Genetic Test help choose between these medications?
PlexusDx Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptides including GLP1R, GIPR, FTO, and MC4R variants to predict your individual response pattern to GLP-1 and GIP activation. This $99 add-on test (after month one of treatment) identifies whether your genetics favor tirzepatide's dual approach or suggest semaglutide may prove equally effective, personalizing your medication selection.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Where to Place Wegovy Shot: A Guide to Comfortable and Effective Injections
Navigating Your Journey: How Often Should You Increase Your Mounjaro Dose?